JP3192235B2 - External preparation for skin - Google Patents

External preparation for skin

Info

Publication number
JP3192235B2
JP3192235B2 JP22773592A JP22773592A JP3192235B2 JP 3192235 B2 JP3192235 B2 JP 3192235B2 JP 22773592 A JP22773592 A JP 22773592A JP 22773592 A JP22773592 A JP 22773592A JP 3192235 B2 JP3192235 B2 JP 3192235B2
Authority
JP
Japan
Prior art keywords
skin
vitamin
external preparation
present
benzophenone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP22773592A
Other languages
Japanese (ja)
Other versions
JPH0632717A (en
Inventor
威 柳田
興彦 阪本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16865546&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP3192235(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP22773592A priority Critical patent/JP3192235B2/en
Priority to EP93914997A priority patent/EP0608433B1/en
Priority to AT04000012T priority patent/ATE365530T1/en
Priority to US08/204,286 priority patent/US5484816A/en
Priority to ES93914997T priority patent/ES2221921T3/en
Priority to PCT/JP1993/000969 priority patent/WO1994001074A1/en
Priority to AT93914997T priority patent/ATE266999T1/en
Priority to EP04000012A priority patent/EP1433477B1/en
Priority to EP06075806A priority patent/EP1714640A1/en
Priority to KR1019940700795A priority patent/KR100295030B1/en
Priority to ES04000012T priority patent/ES2289370T3/en
Priority to DE69333526T priority patent/DE69333526T2/en
Publication of JPH0632717A publication Critical patent/JPH0632717A/en
Priority to US08/429,905 priority patent/US6024941A/en
Publication of JP3192235B2 publication Critical patent/JP3192235B2/en
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明はビタミンAおよび/また
はその脂肪酸エステルの安定性を著しく向上した皮膚外
用剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an external preparation for skin which has significantly improved stability of vitamin A and / or its fatty acid ester.

【0002】[0002]

【従来の技術】ビタミンAおよび/またはその脂肪酸エ
ステルは皮膚角化症等の予防、治療や、皮膚老化の防
止、回復に有効な成分であることが知られている。
2. Description of the Related Art It is known that vitamin A and / or its fatty acid ester are effective components for preventing and treating cutaneous keratosis and the like, and for preventing and recovering skin aging.

【0003】しかしながらビタミンAおよび/またはそ
の脂肪酸エステルは構造的に極めて不安定であり、光、
空気、熱、金属イオン等により容易に種々の異性化、分
解、重合等を起こすため、安定に皮膚外用剤に配合する
ことが困難であった。
[0003] However, vitamin A and / or its fatty acid esters are extremely unstable structurally,
Since various isomerizations, decompositions, and polymerizations are easily caused by air, heat, metal ions, and the like, it has been difficult to stably blend the composition into an external preparation for skin.

【0004】[0004]

【発明が解決しようとする課題】本発明者らは係る事情
に鑑み鋭意研究の結果、ビタミンAおよび/またはその
脂肪酸エステルとともに、水溶性ベンゾフェノン系化合
物の一種または二種以上を配合すればビタミンAおよび
/またはその脂肪酸エステルの安定性が著しく向上する
ことを見出し、本発明を完成するに至った。
DISCLOSURE OF THE INVENTION The present inventors have conducted intensive studies in view of the above circumstances and found that vitamin A and / or a fatty acid ester thereof may be mixed with one or more water-soluble benzophenone compounds to obtain vitamin A. And / or found that the stability of the fatty acid ester is remarkably improved, and completed the present invention.

【0005】[0005]

【課題を解決するための手段】すなわち本発明の要旨
は、ビタミンAと共に、水溶性ベンゾフェノン系化合物
の一種または二種以上を配合したことを特徴とする皮膚
外用剤に存在する。また本発明の要旨は、ビタミンAの
脂肪酸エステルの一種または二種以上と共に、水溶性ベ
ンゾフェノン系化合物(オキシベンゾスルホン酸、2−
ヒドロキシ−4−メトキシベンゾフェノンを除く)の一
種または二種以上を配合したことを特徴とする皮膚外用
剤に存在する。
That is, the gist of the present invention resides in an external preparation for skin characterized in that one or more water-soluble benzophenone compounds are blended together with vitamin A. The gist of the present invention is that a water-soluble benzophenone-based compound (oxybenzosulfonic acid, 2-
(Except for hydroxy-4-methoxybenzophenone) or a combination thereof.

【0006】以下本発明の構成について詳述する。Hereinafter, the configuration of the present invention will be described in detail.

【0007】本発明にもちいられるビタミンAおよび/
またはその脂肪酸エステルとしては、ビタミンA(別
称:レチノール)、ビタミンA酢酸エステル(別称:酢
酸レチノール)、ビタミンAパルミチン酸エステル(別
称:パルミチン酸レチノール)が例示され、all−ト
ランス型または13−シス型であることが望ましく、そ
れらの混合物であっても構わない。さらに水産動物の新
鮮な肝臓および幽門垂から得た脂肪油、およびその濃縮
物なども含まれる。
[0007] Vitamin A and / or used in the present invention
Examples of the fatty acid ester include vitamin A (also known as retinol), vitamin A acetate (also known as retinol acetate), and vitamin A palmitate (also known as retinol palmitate), and all-trans or 13-cis. It is preferably a mold, and a mixture thereof may be used. It also includes fatty oils obtained from fresh liver and pylorus of marine animals, and concentrates thereof.

【0008】本発明に従って皮膚外用剤に配合される量
としては特に制限はないが、ビタミンAとしての肌への
効果を考えると0.0001重量%以上であり、ビタミ
ンAの効果を強く訴求するためには好ましくは0.00
1重量%以上である。配合上限は皮膚外用剤としての性
質上好ましくは10重量%である。
[0008] The amount to be incorporated into the external preparation for skin according to the present invention is not particularly limited, but considering the effect of vitamin A on the skin, the amount is 0.0001% by weight or more, and the effect of vitamin A is strongly appealed. Is preferably 0.00
1% by weight or more. The upper limit of the compounding amount is preferably 10% by weight in view of the properties as an external preparation for skin.

【0009】本発明に用いられる水溶性ベンゾフェノン
系化合物としては2−ヒドロキシー4−メトキシベンゾ
フェノン−5−スルホン酸(以下ベンゾフェノン−4)
およびその塩、2−ヒドロキシ−4−メトキシベンゾフ
ェノン−5−スルホン酸ナトリウム(以下ベンゾフェノ
ン−5)2,2’−ジヒドロキシ−4,4’−ジメトキ
シベンゾフェノン−5,5’−ジスルホン酸ジナトリウ
ム(以下ベンゾフェノン−9)などが例示される。
The water-soluble benzophenone compound used in the present invention is 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid (hereinafter referred to as benzophenone-4).
And a salt thereof, sodium 2-hydroxy-4-methoxybenzophenone-5-sulfonate (hereinafter, benzophenone-5), disodium 2,2′-dihydroxy-4,4′-dimethoxybenzophenone-5,5′-disulfonate (hereinafter, referred to as “sodium salt”). Benzophenone-9) and the like.

【0010】本発明の皮膚外用剤に配合される量として
は、0.001重量%以上であり、配合の上限は特に限
定できないが、極端に多量に配合した場合には本発明の
効果を損なうものではないものの、結晶の析出等により
皮膚外用剤としての品質が保てなくなる。好ましくは5
重量%以下である。
The amount to be incorporated into the skin external preparation of the present invention is 0.001% by weight or more, and the upper limit of the composition is not particularly limited. However, the quality as an external preparation for skin cannot be maintained due to precipitation of crystals and the like. Preferably 5
% By weight or less.

【0011】本発明におけるベンゾフェノンの効果を説
明する。
The effect of benzophenone in the present invention will be described.

【0012】本発明の皮膚外用剤には前述の必須成分以
外に通常化粧品や医薬部外品に用いられる他の成分、例
えば保湿剤、界面活性剤、防腐剤、水、アルコール、増
粘剤、油分、薬剤、キレート剤、香料、色剤、紫外線吸
収剤などが必要に応じて本発明の効果を損なわない範囲
で配合できる。
In addition to the above-mentioned essential components, the skin external preparation of the present invention contains other components usually used in cosmetics and quasi-drugs, such as humectants, surfactants, preservatives, water, alcohol, thickeners, Oils, drugs, chelating agents, fragrances, coloring agents, ultraviolet absorbers, and the like can be added as needed within a range that does not impair the effects of the present invention.

【0013】[0013]

【実施例】次に本発明を実施例によりざらに詳細に説明
するが、本発明はこれにより限定されるものではない。
EXAMPLES Next, the present invention will be roughly described in detail with reference to examples, but the present invention is not limited thereto.

【0014】[0014]

【表1】 [Table 1]

【0015】実施例1及び2では比較例に比べ酢酸レチ
ノールの安定性が向上しているが、これは本発明にした
がって水溶性ベンゾフェノン化合物を添加した効果であ
る。
In Examples 1 and 2, the stability of retinol acetate is improved as compared with the comparative example. This is the effect of adding the water-soluble benzophenone compound according to the present invention.

【0016】実施例1、2および比較例1、2の製法と
温度試験方法 エタノールに、トコフェロール、オクチルメトキシシン
ナメート、オレイルアルコール、メチルパラベン、PO
E(20)オクチルドデシルエーテルを40℃で完全溶
解したのち酢酸レチノールを完全溶解し、速に冷却しア
ルコール部とする。その他の成分を精製水に溶解した水
部にアルコール部を添加しそののち褐色ガラス製サンプ
ル管に密封し、さらにアルミホイルで包み完全遮光し、
40℃恒温槽に保管する。
The manufacturing methods of Examples 1 and 2 and Comparative Examples 1 and 2
Temperature test method Tocopherol, octyl methoxycinnamate, oleyl alcohol, methyl paraben, PO
E (20) After completely dissolving octyldodecyl ether at 40 ° C., completely dissolve retinol acetate and rapidly cool to make an alcohol part. The alcohol part was added to the water part obtained by dissolving the other components in purified water, then sealed in a brown glass sample tube, further wrapped in aluminum foil and completely shielded from light,
Store in a 40 ° C constant temperature bath.

【0017】酢酸レチノールの定量方法 日本薬局方(第十一改正) ビタミンA定量法第1法に
したがってイソプロパノールを用いた吸光度測定法によ
り定量を実施した。
Quantitative method of retinol acetate Japanese Pharmacopoeia (11th edition) Vitamin A quantification was carried out by an absorbance measurement method using isopropanol in accordance with the first method.

【0018】[0018]

【表2】 [Table 2]

【0019】実施例3及び4では比較例に比べレチノー
ルの安定性が向上しているが、これは本発明に係る効果
である。
In Examples 3 and 4, the stability of retinol is improved as compared with the comparative example. This is an effect according to the present invention.

【0020】実施例3、4および比較例3、4の製法と
温度試験方法 BHT、トコフェロールを含む各油性成分と界面活性剤
を70℃で完全溶解したのち、乳化直前にレチノールを
完全溶解し油相とする。グリセリン、プロピレングリコ
ール、カルボキシビニルポリマー、苛性カリ、ベンゾフ
ェノン−9およびベンゾフェノン−5を精製水に完全溶
解し70℃に加温した水相中に油相を加え、ホモミキサ
ー型乳化機により乳化する。次いで熱交換器により30
℃まで冷却処理を施し、乳液を得る。乳液は金属コート
を施したガラス瓶に充填し、密封して40℃恒温槽に保
管する。
The production methods of Examples 3 and 4 and Comparative Examples 3 and 4
Temperature test method After the oil components including BHT and tocopherol and the surfactant are completely dissolved at 70 ° C, retinol is completely dissolved immediately before emulsification to obtain an oil phase. Glycerin, propylene glycol, carboxyvinyl polymer, caustic potash, benzophenone-9 and benzophenone-5 are completely dissolved in purified water, and the oil phase is added to an aqueous phase heated to 70 ° C, and emulsified by a homomixer type emulsifier. Then heat exchanger 30
Cooling treatment to ° C. gives an emulsion. The emulsion is filled in a glass bottle coated with a metal, sealed, and stored in a constant temperature bath at 40 ° C.

【0021】レチノールの定量方法 エタノールを用いて、325nmでの吸光度測定法によ
り測定した。実施例、比較例それぞれからレチノールを
抜去した試料を調製し、325nmにおける吸収を測定
して基剤の吸光度として補正した。 (実施例、比較例の試料の325nmの吸光度)−(抜
去品の吸光度)=レチノールの吸光度 計算にあたっては吸収極大 325nm、E(1%,1
cm)=1835とした。
Determination method of retinol The measurement was carried out by measuring the absorbance at 325 nm using ethanol. Samples from which retinol was removed from each of the examples and comparative examples were prepared, and the absorbance at 325 nm was measured to correct the absorbance of the base. (Absorbance at 325 nm of samples of Examples and Comparative Examples) − (Absorbance of extracted product) = Absorbance of retinol In calculating, absorption maximum 325 nm, E (1%, 1)
cm) = 1835.

【0022】 実施例5 化粧水 (重量%) オレイルアルコール 0.002 酢酸レチノール 0.0001 POE(50)オレイルエーテル 0.7 乳酸 0.01 クエン酸三ナトリウム 0.09 エタノール 8 グリセリン 2 メチルパラベン 0.2 ベンゾフェノン−12 2.5 ベンゾフェノン−5 2.5 精製水 全体を100とする量Example 5 Lotion (wt%) Oleyl alcohol 0.002 Retinol acetate 0.0001 POE (50) Oleyl ether 0.7 Lactic acid 0.01 Trisodium citrate 0.09 Ethanol 8 Glycerin 2 Methylparaben 0.2 Benzophenone-12 2.5 Benzophenone-5 2.5 Purified water 100

【0023】[0023]

【0024】 実施例6 クリーム (重量%) スクワラン 15 2−エチルヘキサン酸トリグリセリド 8 イソプロピルミリステート 7 α−トコフェロール 0.05 レチノール 0.3 ワセリン 2 ブチルパラベン 0.1 プロピルパラベン 0.1 オレイン酸モノグリセリド 3 ジグリセリンジイソステアレート 2 PEG400ジオレエート 1 グリセリン 10 ジプロピレングリコール 5 エデト酸二ナトリウム 0.01 ベンゾフェノン−4 0.03 トリエタノールアミン 0.04 精製水 全体を100とする量Example 6 Cream (% by weight) Squalane 15 2-Ethylhexanoic acid triglyceride 8 Isopropyl myristate 7 α-Tocopherol 0.05 Retinol 0.3 Vaseline 2 Butylparaben 0.1 Propylparaben 0.1 Monoglyceride oleate 3 Diglycerin diisostearate 2 PEG400 dioleate 1 glycerin 10 dipropylene glycol 5 disodium edetate 0.01 benzophenone-4 0.03 triethanolamine 0.04 purified water

【0025】 実施例7 オイルジェル (重量%) 2−エチルヘキサン酸トリグリセリド 60 POE(20)オクチルドデシルエーテル 16 レチノール 0.1 グリセリン 16 ベンゾフェノン−5 0.05 精製水 全体を100とする量Example 7 Oil gel (% by weight) 2-Ethylhexanoic acid triglyceride 60 POE (20) octyldodecyl ether 16 retinol 0.1 glycerin 16 benzophenone-5 0.05 Amount of purified water as 100

【0026】実施例5〜7の皮膚外用剤は日常的な使用
においてビタミンAおよび/またはその脂肪酸エステル
の安定性に優れたものであった。
The skin external preparations of Examples 5 to 7 were excellent in stability of vitamin A and / or its fatty acid ester in daily use.

【0027】[0027]

【発明の効果】本発明の皮膚外用剤においては水溶性ベ
ンゾフェノン系化合物を配合することによりビタミンA
および/またはその脂肪酸エステルの安定性を著しく向
上させることができる。
EFFECT OF THE INVENTION In the external preparation for skin of the present invention, vitamin A can be prepared by blending a water-soluble benzophenone compound.
And / or the stability of the fatty acid ester thereof can be significantly improved.

フロントページの続き (58)調査した分野(Int.Cl.7,DB名) A61K 7/00 A61K 7/48 Continuation of front page (58) Field surveyed (Int.Cl. 7 , DB name) A61K 7/00 A61K 7/48

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 ビタミンAと共に、水溶性ベンゾフェノ
ン系化合物の一種または二種以上を配合したことを特徴
とする皮膚外用剤。
1. An external preparation for skin, comprising one or more water-soluble benzophenone compounds together with vitamin A.
【請求項2】 ビタミンAの脂肪酸エステルの一種また
は二種以上と共に、水溶性ベンゾフェノン系化合物(オ
キシベンゾスルホン酸、2−ヒドロキシ−4−メトキシ
ベンゾフェノンを除く)の一種または二種以上を配合し
たことを特徴とする皮膚外用剤。
2. One or more water-soluble benzophenone compounds (excluding oxybenzosulfonic acid and 2-hydroxy-4-methoxybenzophenone) are blended with one or more fatty acid esters of vitamin A. An external preparation for skin characterized by the following.
JP22773592A 1992-07-13 1992-07-13 External preparation for skin Expired - Fee Related JP3192235B2 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
JP22773592A JP3192235B2 (en) 1992-07-13 1992-07-13 External preparation for skin
EP06075806A EP1714640A1 (en) 1992-07-13 1993-07-13 Stabilised external skin treatment composition comprising retinol.
ES04000012T ES2289370T3 (en) 1992-07-13 1993-07-13 STABILIZED COMPOSITION FOR EXTERNAL SKIN TREATMENT THAT RETINOL INCLUDES.
US08/204,286 US5484816A (en) 1992-07-13 1993-07-13 External skin treatment composition
ES93914997T ES2221921T3 (en) 1992-07-13 1993-07-13 COMPOSITION FOR DERMATOLOGICAL PREPARATION.
PCT/JP1993/000969 WO1994001074A1 (en) 1992-07-13 1993-07-13 Composition for dermatologic preparation
AT93914997T ATE266999T1 (en) 1992-07-13 1993-07-13 DERMATOLOGICAL COMPOSITION
EP04000012A EP1433477B1 (en) 1992-07-13 1993-07-13 Stabilised external skin treatment composition comprising retinol
EP93914997A EP0608433B1 (en) 1992-07-13 1993-07-13 Composition for dermatologic preparation
KR1019940700795A KR100295030B1 (en) 1992-07-13 1993-07-13 Skin external composition
AT04000012T ATE365530T1 (en) 1992-07-13 1993-07-13 STABILIZED SKIN CARE PRODUCT CONTAINING RETINOL FOR EXTERNAL USE
DE69333526T DE69333526T2 (en) 1992-07-13 1993-07-13 DERMATOLOGICAL COMPOSITION
US08/429,905 US6024941A (en) 1992-07-13 1995-04-27 External skin treatment composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22773592A JP3192235B2 (en) 1992-07-13 1992-07-13 External preparation for skin

Publications (2)

Publication Number Publication Date
JPH0632717A JPH0632717A (en) 1994-02-08
JP3192235B2 true JP3192235B2 (en) 2001-07-23

Family

ID=16865546

Family Applications (1)

Application Number Title Priority Date Filing Date
JP22773592A Expired - Fee Related JP3192235B2 (en) 1992-07-13 1992-07-13 External preparation for skin

Country Status (1)

Country Link
JP (1) JP3192235B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08245362A (en) * 1995-03-08 1996-09-24 Seikagaku Kogyo Co Ltd External agent for preventing ultraviolet damage

Also Published As

Publication number Publication date
JPH0632717A (en) 1994-02-08

Similar Documents

Publication Publication Date Title
US5093360A (en) Retinal, derivatives and their therapeutic use
PT715856E (en) Keratin-storable antifungal composition for external use
BRPI0115953B1 (en) phosphate derivative complexes
JP2860748B2 (en) Stable hydrocortisone butyrate-containing cream
JPH064529B2 (en) External skin preparation
JP3192235B2 (en) External preparation for skin
JP3192234B2 (en) External preparation for skin
JP2983311B2 (en) External preparation for skin
JP3417419B2 (en) External preparation for skin
JP3313148B2 (en) External preparation for skin
JP2696523B2 (en) Anti-dandruff agent and hair cosmetic
EP0147476B1 (en) Gel preparations for external application
JP2794252B2 (en) External preparation for skin
JP2906269B2 (en) External preparation for skin
JPH0632713A (en) Skin external preparation
JP3280712B2 (en) External preparation for skin
JP2003012496A (en) Stable urea-containing composition for external use
JP2003012497A (en) Urea-containing composition for external use
JPH0632710A (en) Skin external preparation
JP3150781B2 (en) External preparation for skin
FR2544198A1 (en) TOPICAL PHARMACEUTICAL COMPOSITIONS BASED ON MECLOPHENAMIC ACID
JP3109623B2 (en) Skin whitening agent
JP3455553B2 (en) External preparation for skin
JP3126539B2 (en) Skin roughness improver
JPH0632718A (en) External preparation for skin

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20010508

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090525

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090525

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100525

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110525

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110525

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120525

Year of fee payment: 11

LAPS Cancellation because of no payment of annual fees